365 related articles for article (PubMed ID: 33522500)
21. AMP Kinase Activation is Selectively Disrupted in the Ventral Midbrain of Mice Deficient in Parkin or PINK1 Expression.
Hang L; Thundyil J; Goh GWY; Lim KL
Neuromolecular Med; 2019 Mar; 21(1):25-32. PubMed ID: 30411223
[TBL] [Abstract][Full Text] [Related]
22. In search of early neuroradiological biomarkers for Parkinson's Disease: Alterations in resting state functional connectivity and gray matter microarchitecture in PINK1 -/- rats.
Cai X; Qiao J; Knox T; Iriah S; Kulkarni P; Madularu D; Morrison T; Waszczak B; Hartner JC; Ferris CF
Brain Res; 2019 Mar; 1706():58-67. PubMed ID: 30389398
[TBL] [Abstract][Full Text] [Related]
23. Outlook of PINK1/Parkin signaling in molecular etiology of Parkinson's disease, with insights into
Wang Z; Chan SW; Zhao H; Miu KK; Chan WY
Zool Res; 2023 May; 44(3):559-576. PubMed ID: 37161651
[TBL] [Abstract][Full Text] [Related]
24. [Animal models for familial Parkinson's disease].
Takahashi R
Rinsho Shinkeigaku; 2007 Nov; 47(11):938-40. PubMed ID: 18210841
[TBL] [Abstract][Full Text] [Related]
25. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
[TBL] [Abstract][Full Text] [Related]
26. New Developments in Genetic rat models of Parkinson's Disease.
Creed RB; Goldberg MS
Mov Disord; 2018 May; 33(5):717-729. PubMed ID: 29418019
[TBL] [Abstract][Full Text] [Related]
27. Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease.
Triplett JC; Zhang Z; Sultana R; Cai J; Klein JB; Büeler H; Butterfield DA
J Neurochem; 2015 Jun; 133(5):750-65. PubMed ID: 25626353
[TBL] [Abstract][Full Text] [Related]
28. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.
Clark IE; Dodson MW; Jiang C; Cao JH; Huh JR; Seol JH; Yoo SJ; Hay BA; Guo M
Nature; 2006 Jun; 441(7097):1162-6. PubMed ID: 16672981
[TBL] [Abstract][Full Text] [Related]
29. Electroacupuncture Promotes Recovery of Motor Function and Reduces Dopaminergic Neuron Degeneration in Rodent Models of Parkinson's Disease.
Lin JG; Chen CJ; Yang HB; Chen YH; Hung SY
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837077
[TBL] [Abstract][Full Text] [Related]
30. Loss-of-function rodent models for parkin and PINK1.
Oliveras-Salvá M; Van Rompuy AS; Heeman B; Van den Haute C; Baekelandt V
J Parkinsons Dis; 2011; 1(3):229-51. PubMed ID: 23939304
[TBL] [Abstract][Full Text] [Related]
31. Polylysine-modified polyethylenimine (PEI-PLL) mediated VEGF gene delivery protects dopaminergic neurons in cell culture and in rat models of Parkinson's Disease (PD).
Sheikh MA; Malik YS; Xing Z; Guo Z; Tian H; Zhu X; Chen X
Acta Biomater; 2017 May; 54():58-68. PubMed ID: 28025049
[TBL] [Abstract][Full Text] [Related]
32. Diaminodiphenyl sulfone-induced parkin ameliorates age-dependent dopaminergic neuronal loss.
Lee YI; Kang H; Ha YW; Chang KY; Cho SC; Song SO; Kim H; Jo A; Khang R; Choi JY; Lee Y; Park SC; Shin JH
Neurobiol Aging; 2016 May; 41():1-10. PubMed ID: 27103513
[TBL] [Abstract][Full Text] [Related]
33. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
34. Loss of Parkin contributes to mitochondrial turnover and dopaminergic neuronal loss in aged mice.
Noda S; Sato S; Fukuda T; Tada N; Uchiyama Y; Tanaka K; Hattori N
Neurobiol Dis; 2020 Mar; 136():104717. PubMed ID: 31846738
[TBL] [Abstract][Full Text] [Related]
35. Parkin loss-of-function pathology: Premature neuronal senescence induced by high levels of reactive oxygen species?
Buhlman LM
Mech Ageing Dev; 2017 Jan; 161(Pt A):112-120. PubMed ID: 27374431
[TBL] [Abstract][Full Text] [Related]
36. Molecular interaction between parkin and PINK1 in mammalian neuronal cells.
Um JW; Stichel-Gunkel C; Lübbert H; Lee G; Chung KC
Mol Cell Neurosci; 2009 Apr; 40(4):421-32. PubMed ID: 19167501
[TBL] [Abstract][Full Text] [Related]
37. Loss of PINK1 enhances neurodegeneration in a mouse model of Parkinson's disease triggered by mitochondrial stress.
Moisoi N; Fedele V; Edwards J; Martins LM
Neuropharmacology; 2014 Feb; 77():350-7. PubMed ID: 24161480
[TBL] [Abstract][Full Text] [Related]
38. Nitric oxide induction of Parkin translocation in PTEN-induced putative kinase 1 (PINK1) deficiency: functional role of neuronal nitric oxide synthase during mitophagy.
Han JY; Kang MJ; Kim KH; Han PL; Kim HS; Ha JY; Son JH
J Biol Chem; 2015 Apr; 290(16):10325-35. PubMed ID: 25716315
[TBL] [Abstract][Full Text] [Related]
39. rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease.
Manfredsson FP; Burger C; Sullivan LF; Muzyczka N; Lewin AS; Mandel RJ
Exp Neurol; 2007 Oct; 207(2):289-301. PubMed ID: 17678648
[TBL] [Abstract][Full Text] [Related]
40. Dysregulation of parkin in the substantia nigra of db/db and high-fat diet mice.
Khang R; Park C; Shin JH
Neuroscience; 2015 May; 294():182-92. PubMed ID: 25779963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
